Professor Anneke Lucassen
Anneke was appointed Director of the CPM in August 2021. Anneke trained in Medicine and specialised in Clinical Genetics. After a DPhil identifying genetic factors in diabetes, she set up an interdisciplinary research programme exploring the ethical, legal and social aspects of integrating advances in genetics (and other forms of big data) into healthcare and society. She is consultant in the Oxford Clinical Genetics Service.
Much more information on Anneke’s research can be found here.
Recent publications
BRCA-DIRECT digital pathway for diagnostic germline genetic testing within a UK breast oncology setting: a randomised, non-inferiority trial
Bethany Torr, Christopher Jones, Grace Kavanaugh, et al (2024), British Journal of Cancer, 131
The PS4-likelihood ratio calculator: flexible allocation of evidence weighting for case-control data in variant classification.
Charlie F Rowlands, Alice Garrett, Sophie Allen, et al (2024), Journal of medical genetics, 61
Population screening requires robust evidence-genomics is no exception.
Clare Turnbull, Helen V Firth, Andrew OM Wilkie, et al (2024), Lancet (London, England), 403
Prospective study design and data analysis in UK Biobank
Naomi Allen, Naomi E Allen, Ben Lacey, et al (2024), Science Translational Medicine, 16
Ethical preparedness in genomic medicine: how NHS clinical scientists navigate ethical issues
Kate Sahan, Kate Lyle, Helena Carley, et al (2024), Journal of Medical Ethics, 50